Cargando…
Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
Autores principales: | Lioger, Bertrand, Ferreira-Maldent, Nicole, Cottier, Jean Philippe, Debiais, Séverine, Gyan, Emmanuel, Maillot, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949984/ https://www.ncbi.nlm.nih.gov/pubmed/27458597 http://dx.doi.org/10.1212/NXI.0000000000000253 |
Ejemplares similares
-
Rituximab-Associated Flare of Cryoglobulinemic Vasculitis
por: Sy-Go, Janina Paula T., et al.
Publicado: (2021) -
Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
por: Fornero, Léa, et al.
Publicado: (2023) -
Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab
por: Fenoglio, Roberta, et al.
Publicado: (2022) -
Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
por: Leśniak, Ksymena, et al.
Publicado: (2021) -
Therapeutic Potential of Rituximab in Managing Hepatitis C-Associated Cryoglobulinemic Vasculitis: A Systematic Review
por: Covic, Andreea, et al.
Publicado: (2023)